Astronics Corporation

Astronics is the rare aerospace mid-cap that has rerated from 27 USD in May 2024 to 78 USD in May 2026 — a triple in 24 months — without diluting shareholders. The Buffalo, New York based company designs the in-seat power systems, cabin lighting, and avionics modules that go into virtually every Boeing 787, 777X, and Airbus A350. Roughly 80% of revenue is commercial aerospace; the rest is military and test systems for radar/EW programs.

The 2024 trough was the buying opportunity in hindsight. The 787 production rate was stuck at 4 per month, the 737 MAX was post-Alaska-Airlines-door-plug crisis, and FAA quality reviews extended every Tier-1 supplier delivery clock. By 2026 the 737 MAX is at 38 per month and ramping toward 50, the 787 has hit 7 per month with a target of 10, and the 777X is in final certification with deliveries beginning Q4 2026.

Each new aircraft generates roughly 350,000 USD of Astronics in-seat power and cabin electronics content. The combination of OEM rate ramp plus expanding installed base plus retrofit programs at the major carriers is feeding a 25-35% revenue CAGR through 2027. The 2026 forward P/E of 25x reflects that growth but does not yet price in the 777X content premium.

Astronics has attracted a notable cluster of small-cap-focused funds in 2025. Royce & Associates (Chuck Royce small-cap value vehicle) initiated in Q2 2025 at 38 USD and remains top-10 holder. Wasatch Advisors built a 4% position in Q4 2025. Both are funds that historically hold 3-5 years and rarely chase momentum — their entry signals fundamental conviction not technical trading.

FMR (Fidelity) and Vanguard are the largest passive holders. The 13F-relevant active flow in 2026 shows Park West Asset Management (Peter Park) as a new top-20 entrant — a healthcare and industrial activist with a track record of pushing for operational efficiency and capital allocation discipline in mid-cap manufacturers.

Insider activity in 2025 was modestly positive. Founder and CEO Peter Gundermann (76 years old) sold roughly 60,000 shares under a 10b5-1 plan at an average of 56 USD — well below current prices. No 10b5-1 sells from any executive in 2026. The combination of family-led ownership (Gundermann holds approximately 4.5% personally) and ongoing institutional accumulation is a clean alignment signal.

Astronics trades at a forward P/E of 25x on 2026 consensus EPS of 3.16 USD, against the aerospace small-cap median of 22x. The premium reflects content-per-aircraft expansion plus Test Systems counter-cyclical backlog. EV/EBITDA at 14x is in line with TransDigm at 18x (the structural ceiling for high-margin aerospace components) and HEICO at 16x. Sell-side targets range from 65 USD (William Blair, base case assuming 737 MAX rate slip) to 105 USD (Truist, bull case at 777X content ramp plus Test Systems acceleration). Fair value at 85-95 USD implies 10-20% upside from current 78 USD. The lack of dividend is offset by share buyback authorization and ongoing debt reduction.

1. August 2026: Q2 2026 results — first quarter with 737 MAX at 38 per month rate and Boeing 787 above 7 per month
2. Q4 2026: Boeing 777X first delivery to Emirates — start of new content ramp generating ~425k USD per aircraft
3. Q1 2027: 2027 guidance and Test Systems backlog conversion update — first full year with 777X plus MAX rate above 40

Astronics is the cleanest pick-and-shovel play on the Boeing recovery I know. You are not betting on Boeing balance sheet, you are not betting on management — you are betting that every plane Boeing actually delivers contains six-figures of Astronics content. The 777X content premium and Test Systems counter-cyclical hedge make this a more diversified bet than the simple Boeing-recovery thesis suggests. My main concern is the valuation; at 25x forward P/E the easy money is behind us, and any Boeing stumble would hurt. I size ATRO at 2-3% portfolio weight and would trim above 95 USD or add aggressively if a Boeing crisis pushes ATRO below 55 USD.